移动IP综述

论述了移动IP的概念和发展过程，分析了国内外对移动IP研究的重点问题及其方法，对移动IP的发展方向进行了归纳和总结，并提出了有关用的问题。     

某双曲拱坝的体型调整

在某砌石双曲拱坝施工中,由于施工放样的错误,使已建拱坝坝轴线偏离了设计坝轴线,为此需要重新调整拱坝体型。根据已建成的拱冠梁上游面曲线重新确定新的曲线方程,待建部分用新的曲线方程延伸,经空间有限元的应力变形分析,认为调整后的拱坝体型可行。现已付予实施。     

HDTV信源解码器

本论文提出一种基于TMS320C6701 DSP实现HDTV信源解码器的方案。用C6701实现系统控制、解复用、AC-3音频解码,用STi7000视频解码。与现有的HDTV信源解码方案相比,本方案将核心芯片由三片(系统控制+解复用、视频解码和音频解码)减少到两片,有利于系统集成,代表了HDTV信源解码器的发展方向之一。     

3COM三层交换机在城域网中的应用

介绍了3Com三层交换机Switch4900SX在城域网中的具体应用，包括用它进行路由交换、vlan划分等。     

纳米碳酸钙制备过程中添加剂作用机理探讨

采用鼓泡碳化法 ,在最佳反应温度、反应物浓度的条件下 ,考察了添加剂对产物形状及粒径大小的影响 ,得到了直径为 2 0～ 30nm、长径比在 2 0左右且分散性能良好的针状纳米碳酸钙 ,并对添加剂作用机理进行了分析。     

Dy3+激活的几种硼酸盐在VUV-VIS范围的光谱性质

本文报道了SrAl2B2o7:Dy^3 、BaAl2B2O7:Dy^3 、SrAl3BO7:Dy^3 、La2CaB10O19:Dy^3 的紫外－真空紫外（UV－VUV）激发光谱和UV激发下的发射光谱。根据发射光谱讨论了Dy^3 离子在这几种基质中发光的黄蓝比（Y／B）。在VUV激发光谱中推测了Dy^3 的f-d跃迁及电荷迁移态（CTS）和基质吸收的位置。     

氨氮监测中样品蒸馏预处理对结果的影响分析

氨氮监测采用预蒸馏处理后，比色测定结果明显偏低。在样品预蒸馏处理过程中，硼酸作为吸收液，使显色时溶液pH值偏低，导致显色不充分是其主要影响因素。通过采取增加显色剂加入量的方法，解决了显色pH值偏低的问题，得到满意的测定结果。     

High Temperature Oxidation Behavior of La2O3-MosSi3/MoSi2 Composites

The oxidation behavior of 0. 8% La2O3- Mo5Si3/MoSi2 composites at 1200℃ in air was investigated. The results reveal that the oxidation resistance of the material with 0. 8% La2O3 and Mo5Si3 is impaired. The oxidation resistance is decreased with increasing Mo5Si3 content. The mass loss follows a linear law in the initial oxidation. With oxidation time prolonging, a continuous and dense oxidation scale prevents oxygen from diffusing increasing when and leads to mass change a Mo5Si3 content is less than 30%. However, the composite shows ＂PEST＂ with the addition of 40% Mo5Si3. With increasing Mo5Si3 content, the oxidation resistance of 0.8% La2O3- Mo5Si3/MoSi2 decreases. This attributes to the poor oxidation resistance of M05Si3 and the relative density decreasing of 0. 8% La2O3-Mo5Si3/MoSi2 composite.     

Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients

Objective Tacrolimus is an immunosuppressive drug with narrow therapeutic range and wide interindividual variation in its pharmacokinetics. Tacrolimus is a substrate of cytochrome P450(CYP)3A5. The aim of this study was to evaluate whether the A6986G polymorphism is associated with tacrolimus concentration /dose ratio. Methods Fifty-two Chinese renal transplant patients were enrolled in this study. Their body weight, dosage and concentration of tacrolimus were observed. CYP3A5 genotype was determined by polymerase chain reaction followed by restriction fragment length polymorphism analysis. Results A significant association was found between tacrolimus levels per dose/kg/d and CYP3A5 gene A6986G polymorphism (P<0.001). The CYP3A5 * 3 * 3 patients have a significantly higher tacrolimus level/dose than CYP3A5 * 1 * 1 and CYP3A5 * 1 * 3. Conclusions CYP3A5 gene A6986G polymorphism is associated with tacrolimus pharmacokinetics and dose requirements. Pharmacogenetic methods could be employed prospectively to help the dose selection and to individualize immunosuppressive therapy according to the result. Foundation item: Project (03GZ3072) supported by the Science and Technology Department of Hunan Province; project (2004035206) supported by the China Postdoctoral Foundation and project (30300383) supported by the National Natural Sciences Foundation of China